HBV RNA IN SERUM IS A PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING TREATMENT WITH PEG-INTERFERON ALPHA-2a (40KD)

被引：0
|
作者：
van Boemmel, F. [1 ]
van Boemmel, A. [2 ]
He, H. [3 ]
Wat, C. [3 ]
Deichsel, D. [1 ]
Berg, T. [1 ]
Boehm, S. [1 ]
机构：
[1] Univ Leipzig, Gastroenterol & Rheumatol, D-04109 Leipzig, Germany
[2] Max Planck Inst Mol Genet, D-14195 Berlin, Germany
[3] Roche Prod Ltd, Welwyn Garden City, Herts, England
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61255-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1095
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [1] SERUM HBVRNA IS AN EARLY PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH PEG-INTERFERON ALPHA-2A (40kD)
    van Boemmel, F.
    van Boemmel, A.
    Krauel, A.
    He, H.
    Wat, C.
    Pavlovic, V.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S560 - S561
  • [2] Serum HBV RNA is an Early Predictor of HBeAg Seroconversion in Patients with Chronic Hepatitis B (CHB) Treated with Pegylated Interferon Alfa-2a (40KD)
    van Boemmel, Florian
    van Boemmel, Alena
    Krauel, Alexander
    He, Hua
    Wat, Cynthia
    Pavlovic, Vedran
    Yang, Lei
    Deichsel, Danilo
    Berg, Thomas
    Boehm, Stephan
    [J]. HEPATOLOGY, 2015, 62 : 336A - 336A
  • [3] HBV RNA in Serum Is an Early Predictor for HBsAg Loss Following Peg-Interferon Treatment for Patients with Hbeag Positive Chronic Hepatitis B
    Farag, Mina
    Van Campenhout, Margo
    van Bommel, Florian
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    Van Vuuren, Anneke J.
    Berg, Thomas
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    [J]. HEPATOLOGY, 2018, 68 : 1192A - 1192A
  • [4] Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB)
    Piratvisuth, T.
    Lau, G. K. K.
    Marcellin, P.
    Chow, W. C.
    Cooksley, G.
    Fried, M. W.
    Paik, S. W.
    Liaw, Y. F.
    Popescu, M.
    Button, P.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S23 - S23
  • [5] HBeAg and HBV DNA kinetics in HBsAg clearance with peginterferon alpha-2a (40KD) (PEGASYS) treatment for HBeAg-positive chronic hepatitis B (CHB)
    Fried, M. W.
    Liaw, Y. F.
    Luo, K. X.
    Lau, G. K. K.
    Piratvisuth, T.
    Cooksley, G.
    Marcellin, P.
    Flisiak, R.
    Popescu, M.
    Button, P.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S183 - S183
  • [6] A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
    Chen, Xinyue
    Mao, Qianguo
    Xie, Yao
    Dou, Xiaoguang
    Xie, Qing
    Sheng, Jifang
    Gao, Zhiliang
    Zhou, Xiaoling
    Liu, Yingxia
    Zheng, Huanwei
    Zhang, Shuqin
    Li, Shibo
    Zhu, Fusheng
    Xu, Yuqin
    Zhang, Mingxiang
    Hu, Yaoren
    Chen, Xiaoping
    Huang, Yan
    Ren, Hong
    Jia, Jidong
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 249 - 257
  • [7] Peg-Interferon Alpha-2a versus Peg-Interferon Alpha-2b in Nonresponders with HCV Active Chronic Hepatitis: A Pilot Study
    Scotto, Gaetano
    Fazio, Vincenzina
    Fornabaio, Chiara
    Tartaglia, Alessandra
    Di Tullio, Rocco
    Saracino, Annalisa
    Angarano, Gioacchino
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2008, 28 (10): : 623 - 629
  • [8] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Guangjun Song
    Ruifeng Yang
    Qian Jin
    Juan Liu
    Huiying Rao
    Bo Feng
    Yandi Xie
    [J]. BMC Gastroenterology, 23
  • [9] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Song, Guangjun
    Yang, Ruifeng
    Jin, Qian
    Liu, Juan
    Rao, Huiying
    Feng, Bo
    Xie, Yandi
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [10] PEG-interferon A-2A (40KD) with or without ribavirin in the treatment of naive patients with recurrent hepatitis C after transplantation
    Petrolati, A
    Lionetti, R
    Donato, F
    Merli, M
    Burra, P
    Angeli, P
    Strazzabosco, M
    Toti, L
    Manzia, TM
    Tisone, G
    Angelico, M
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : C113 - C113
12345